Literature DB >> 24839006

Residual tumor after unplanned excision reflects clinical aggressiveness for soft tissue sarcomas.

Eisuke Arai1, Hideshi Sugiura, Satoshi Tsukushi, Hiroatsu Nakashima, Hiroshi Urakawa, Eiji Kozawa, Naoki Ishiguro, Yoshihiro Nishida.   

Abstract

The aims of this study are to investigate clinical and pathological factors associated with the existence of residual tumor in reexcised specimens (RTRS) following unplanned excisions for soft tissue sarcomas and to determine whether RTRS has an impact on the oncologic outcome. A total of 113 patients with soft tissue sarcoma who received unplanned excision at the prereferral hospital were treated with additional reexcision at our institutions from 1986 to 2010. Clinical and pathological variables were analyzed as possible factors correlated with the existence of RTRS. These factors in addition to surgical margin in reexcisions were analyzed as factors possibly correlated with the oncological outcome. RTRS was observed in 58 cases (51 %). Histological subtype tended to associate with the presence of RTRS (P = 0.063), particularly in patients with dermatofibrosarcoma protuberances (DFSP) (83 %) and myxofibrosarcoma (100 %), whereas the other factors did not. Five-year local recurrence-free, metastasis-free, and overall survival (LRFS, MFS, and OS) were 93, 96, and 97 %, respectively. Patients with RTRS tended to have lower LRFS (89 %) than those without (97 %, P = 0.067) and had significantly lower MFS (92 %) than those without (100 %, P = 0.043). Other factors had no impact on prognosis. Patients receiving unplanned excision particularly for myxofibrosarcoma and DFSP require reexcision with an adequate surgical margin. Although patients with unplanned excision have a favorable clinical outcome following additional wide reexcision, those with RTRS require careful follow-up.

Entities:  

Mesh:

Year:  2014        PMID: 24839006     DOI: 10.1007/s13277-014-2043-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  16 in total

1.  Outcomes of re-excision after unplanned excisions of soft-tissue sarcomas.

Authors:  Mark W Manoso; Deborah A Frassica; E Gene Deune; Frank J Frassica
Journal:  J Surg Oncol       Date:  2005-09-01       Impact factor: 3.454

2.  Additional wide resection of malignant soft tissue tumors.

Authors:  Hideshi Sugiura; Mitsuru Takahashi; Hirohisa Katagiri; Yoshihiro Nishida; Hiroatsu Nakashima; Masahiro Yonekawa; Hisashi Iwata
Journal:  Clin Orthop Relat Res       Date:  2002-01       Impact factor: 4.176

3.  The impact of residual disease on local recurrence in patients treated by initial unplanned resection for soft tissue sarcoma of the extremity.

Authors:  A M Davis; R A Kandel; J S Wunder; R Unger; J Meer; B O'Sullivan; C N Catton; R S Bell
Journal:  J Surg Oncol       Date:  1997-10       Impact factor: 3.454

4.  The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas.

Authors:  A E Giuliano; F R Eilber
Journal:  J Clin Oncol       Date:  1985-10       Impact factor: 44.544

5.  Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy.

Authors:  Gunar K Zagars; Matthew T Ballo; Peter W T Pisters; Raphael E Pollock; Shreyaskumar R Patel; Robert S Benjamin
Journal:  Cancer       Date:  2003-05-15       Impact factor: 6.860

6.  Local recurrence of disease after unplanned excisions of high-grade soft tissue sarcomas.

Authors:  Benjamin K Potter; Sheila C Adams; J David Pitcher; H Thomas Temple
Journal:  Clin Orthop Relat Res       Date:  2008-09-26       Impact factor: 4.176

7.  Surgical management of soft tissue sarcomas of the hand and foot.

Authors:  Patrick P Lin; Volkan B Guzel; Peter W T Pisters; Gunar K Zagars; Kristin L Weber; Barry W Feig; Raphael E Pollock; Alan W Yasko
Journal:  Cancer       Date:  2002-08-15       Impact factor: 6.860

8.  Residual disease following unplanned excision of soft-tissue sarcoma of an extremity.

Authors:  S Noria; A Davis; R Kandel; J Levesque; B O'Sullivan; J Wunder; R Bell
Journal:  J Bone Joint Surg Am       Date:  1996-05       Impact factor: 5.284

9.  Clinical and treatment outcomes of planned and unplanned excisions of soft tissue sarcomas.

Authors:  Eisuke Arai; Yoshihiro Nishida; Satoshi Tsukushi; Junji Wasa; Naoki Ishiguro
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

10.  The effect of an unplanned excision of a soft-tissue sarcoma on prognosis.

Authors:  C R Chandrasekar; H Wafa; R J Grimer; S R Carter; R M Tillman; A Abudu
Journal:  J Bone Joint Surg Br       Date:  2008-02
View more
  4 in total

1.  Staged Soft Tissue Reconstruction Following Sarcoma Excision with Anticipated Large Cutaneous Defects: An Oncologically Safe Alternative.

Authors:  Geoffrey W Siegel; William M Kuzon; Jill M Hasen; J Sybil Biermann
Journal:  Iowa Orthop J       Date:  2016

2.  Outcomes of unplanned sarcoma excision: impact of residual disease.

Authors:  Chris Charoenlap; Jungo Imanishi; Takaaki Tanaka; John Slavin; Samuel Y Ngan; Sarat Chander; Michelle Maree Dowsey; Chatar Goyal; Peter F M Choong
Journal:  Cancer Med       Date:  2016-03-01       Impact factor: 4.452

3.  The Impact of Unplanned Excision on the Outcomes of Patients With Soft Tissue Sarcoma of the Trunk and Extremity: A Propensity Score Matching Analysis.

Authors:  Yao Liang; Tian-Hui Guo; Bu-Shu Xu; Dong-Chun Hong; Hai-Bo Qiu; Zhi-Wei Zhou; Xing Zhang
Journal:  Front Oncol       Date:  2021-01-22       Impact factor: 6.244

Review 4.  Re-excision after unplanned excision of soft tissue sarcoma: A systematic review and metanalysis. The rationale of systematic re-excision.

Authors:  Federico Sacchetti; Andac Celasun Alsina; Riccardo Morganti; Matteo Innocenti; Lorenzo Andreani; Francesco Muratori; Guido Scoccianti; Francesca Totti; Domenico Andrea Campanacci; Rodolfo Capanna
Journal:  J Orthop       Date:  2021-05-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.